insights_auto
Why is GANX down 4.82%?
Dive Deeperchevron_right
GANX:NASDAQ
Gain Therapeutics Inc
$1.00
arrow_downward
-4.82%(-0.051) 1D
$1.00
arrow_upward
+0.06% (+0.00060)bedtimeAfter hours
Closed: Nov 20, 4:00:02 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GANX...
Open
$1.02
High
$1.10
Low
$0.97
Mkt. cap
44.50M
Avg. vol.
690.72K
Volume
586.26K
52-wk high
$4.34
52-wk low
$0.94
EPS
-$0.43
Beta
0.29
Shares outstanding
44.52M
No. of employees
21
Open
$1.02
High
$1.10
Low
$0.97
Mkt. cap
44.50M
Avg. vol.
690.72K
Volume
586.26K
52-wk high
$4.34
52-wk low
$0.94
EPS
-$0.43
Beta
0.29
Shares outstanding
44.52M
No. of employees
21
News stories
From web sources and news partners
The Arkansas Democrat-Gazette
·
30 minutes ago
AI-led sell-off drags S&P 500 down by 3.7%
Traders Union
·
3 hours ago
VIX fear index hits highest level since April 2025 as S&P 500 plunges
Trefis
·
1 hour ago
25 S&P 500 Stocks Just Made New 52-Week Lows
BigGo Finance
·
13 hours ago
Goldman Sachs: Year-End S&P 500 Rally Could Lose Half Its Punch as Fear Runs Hot
About Gain Therapeutics Inc
CEO-
Employees21
Founded2017
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitegaintherapeutics.com